
MariMed Inc. – OTC:MRMD
MariMed stock price today
MariMed stock price monthly change
MariMed stock price quarterly change
MariMed stock price yearly change
MariMed key metrics
Market Cap | 137.60M |
Enterprise value | 161.89M |
P/E | 10 |
EV/Sales | 1.20 |
EV/EBITDA | 6.28 |
Price/Sales | 1.01 |
Price/Book | 2.30 |
PEG ratio | 0.1 |
EPS | -0.04 |
Revenue | 152.15M |
EBITDA | 16.13M |
Income | -16.68M |
Revenue Q/Q | 10.33% |
Revenue Y/Y | 10.97% |
Profit margin | 10.05% |
Oper. margin | 18.72% |
Gross margin | 47.73% |
EBIT margin | 18.72% |
EBITDA margin | 10.6% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMariMed stock price history
MariMed stock forecast
MariMed financial statements
Jun 2023 | 36.51M | -958K | -2.62% |
---|---|---|---|
Sep 2023 | 38.8M | -4.25M | -10.98% |
Dec 2023 | 38.89M | -10.16M | -26.14% |
Mar 2024 | 37.93M | -1.29M | -3.42% |
Sep 2025 | 55.2M | 0 | |
---|---|---|---|
Oct 2025 | 58.7M | 0 | |
Dec 2025 | 59.7M | 0 | |
Mar 2026 | 59.3M | 0 |
Analysts Price target
Financials & Ratios estimates
Payout ratio | 0% |
---|
2019 | 0.37% |
---|---|
2020 | 0.25% |
2021 | 0.15% |
2022 | 0.22% |
2023 | 0.16% |
Jun 2023 | 189368000 | 108.46M | 57.28% |
---|---|---|---|
Sep 2023 | 190817000 | 110.95M | 58.15% |
Dec 2023 | 196123000 | 126.20M | 64.35% |
Mar 2024 | 201332000 | 132.51M | 65.82% |
Jun 2023 | 1.27M | -6.49M | -1.13M |
---|---|---|---|
Sep 2023 | 7.9M | -6.21M | -3.66M |
Dec 2023 | 3.23M | -6.34M | 4.5M |
Mar 2024 | 3.21M | -4.26M | 1.64M |
MariMed alternative data
Aug 2023 | 592 |
---|---|
Sep 2023 | 592 |
Oct 2023 | 592 |
Nov 2023 | 592 |
Dec 2023 | 592 |
Jan 2024 | 592 |
Feb 2024 | 592 |
Mar 2024 | 643 |
Apr 2024 | 643 |
May 2024 | 643 |
Jun 2024 | 643 |
Jul 2024 | 643 |
MariMed other data
Period | Buy | Sel |
---|---|---|
Oct 2023 | 0 | 74862 |
Mar 2024 | 0 | 31877 |
Apr 2024 | 0 | 90236 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | LEVINE JON R director, officer.. | Common stock | 150,000 | N/A | N/A | ||
Option | LEVINE JON R director, officer.. | Restricted Stock Units (RSU) | 150,000 | N/A | N/A | ||
Option | SHAW TIMOTHY officer: Chief Operating Officer | Common stock | 111,111 | N/A | N/A | ||
Option | SHAW TIMOTHY officer: Chief Operating Officer | Restricted Stock Units (RSU) | 111,111 | N/A | N/A | ||
Option | LEVINE JON R director, officer.. | Common stock | 138,889 | N/A | N/A | ||
Option | LEVINE JON R director, officer.. | Restricted Stock Units (RSU) | 138,889 | N/A | N/A | ||
Option | SHAW TIMOTHY officer: Chief Operating Officer | Common stock | 21,667 | N/A | N/A | ||
Option | SHAW TIMOTHY officer: Chief Operating Officer | Restricted Stock Units (RSU) | 21,667 | N/A | N/A | ||
Option | LEVINE JON R director, officer.. | Common stock | 23,333 | N/A | N/A | ||
Option | LEVINE JON R director, officer.. | Restricted Stock Units (RSU) | 23,333 | N/A | N/A |
Quarter | Transcript |
---|---|
Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 7 Mar 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Jon R. Levine (1965) Founder & Chief Financial Officer | $37,490 |
Mr. Robert N. Fireman (1949) Chairman, Pres & Chief Executive Officer | $31,490 |
The Sustainability Of Cannabis Bull Run
Green Thumb: Best House In A Bad Neighborhood
MariMed: Positioning Itself To Thrive In A Post-Rescheduling Environment
Finding The Long-Term Winners In The Cannabis Sector
MariMed: Still Overlooked
Medicine Man Technologies: Why I Am Buying This Stock
MariMed: Another MSO Overlooked
Trulieve Takes A Pause With Big Catalyst Over The Horizon
MariMed: Forgotten MSO
-
What's the price of MariMed stock today?
One share of MariMed stock can currently be purchased for approximately $0.1.
-
When is MariMed's next earnings date?
Unfortunately, MariMed's (MRMD) next earnings date is currently unknown.
-
Does MariMed pay dividends?
No, MariMed does not pay dividends.
-
How much money does MariMed make?
MariMed has a market capitalization of 137.60M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 10.89% to 148.6M US dollars.
-
What is MariMed's stock symbol?
MariMed Inc. is traded on the OTC under the ticker symbol "MRMD".
-
What is MariMed's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of MariMed?
Shares of MariMed can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are MariMed's key executives?
MariMed's management team includes the following people:
- Mr. Jon R. Levine Founder & Chief Financial Officer(age: 60, pay: $37,490)
- Mr. Robert N. Fireman Chairman, Pres & Chief Executive Officer(age: 76, pay: $31,490)
-
Is MariMed founder-led company?
Yes, MariMed is a company led by its founder Mr. Jon R. Levine.
-
How many employees does MariMed have?
As Jul 2024, MariMed employs 643 workers.
-
When MariMed went public?
MariMed Inc. is publicly traded company for more then 13 years since IPO on 11 May 2012.
-
What is MariMed's official website?
The official website for MariMed is marimedinc.com.
-
Where are MariMed's headquarters?
MariMed is headquartered at 10 Oceana Way, Norwood, MA.
-
How can i contact MariMed?
MariMed's mailing address is 10 Oceana Way, Norwood, MA and company can be reached via phone at +61 77955140.
MariMed company profile:

MariMed Inc.
marimedinc.comOTC
260
Drug Manufacturers—Specialty & Generic
Healthcare
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
Norwood, MA 02062
CIK: 0001522767
ISIN: US56782V1070
CUSIP: 56782V107